AngioGenex is a biopharmaceutical company using unique anti-Id (Inhibitor of differentiation) technology initially incubated at Memorial Sloan Kettering Cancer Center, NYC.
50
Sentiment
How do you feel about AGGX?
Link your Stocktwits account
Ask your agent for live sentiment, watchers, trending tickers, and news.